Population Health and Cost-Effectiveness Implications of a “Treat All” Recommendation for HCV: A Review of the Model-Based Evidence

by Lauren E. Cipriano, Jeremy D. Goldhaber-Fiebert
Published 2018-05-01

Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States.

by Shan Liu, Lauren E Cipriano, Mark Holodniy, Jeremy D Goldhaber-Fiebert
Published 2013-01-01

Impact of university re-opening on total community COVID-19 burden.

by Lauren E Cipriano, Wael M R Haddara, Gregory S Zaric, Eva A Enns
Published 2021-01-01

Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users.

by Lauren E Cipriano, Gregory S Zaric, Mark Holodniy, Eran Bendavid, Douglas K Owens, Margaret L Brandeau
Published 2012-01-01

Post-mortem 7 Tesla MRI detection of white matter hyperintensities: A multidisciplinary voxel-wise comparison of imaging and histological correlates

by Austyn D. Roseborough, Kristopher D. Langdon, Robert Hammond, Lauren E. Cipriano, Stephen H. Pasternak, Shawn N. Whitehead, Ali R. Khan
Published 2020-01-01